Michel A. Khalaf's Insider Trades & SAST Disclosures
Michel A. Khalaf's most recent trade in Metlife Inc was a trade of 16,840 Common Stock done at an average price of $85.7 . Disclosure was reported to the exchange on March 3, 2025.
Add Superstar Alert
Note
This is a custom search result for pattern Michel A. Khalaf.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.70 per share. | 03 Mar 2025 | 16,840 | 612,483 (0%) | 0% | 85.7 | 1,443,188 | Common Stock |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 151,991 | 711,550 (0%) | 0% | - | Common Stock | |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.20 per share. | 25 Feb 2025 | 82,227 | 629,323 (0%) | 0% | 82.2 | 6,759,059 | Common Stock |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 58,760 | 559,559 (0%) | 0% | - | Common Stock | |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.91 per share. | 13 Dec 2024 | 26,138 | 521,725 (0%) | 0% | 45.9 | 1,199,996 | Common Stock |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2024 | 26,138 | 0 | - | - | Employee Stock Option (Right to Buy) | |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 82.84 per share. | 13 Dec 2024 | 20,926 | 500,799 (0%) | 0% | 82.8 | 1,733,604 | Common Stock |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.73 per share. | 01 Mar 2024 | 16,381 | 495,587 (0%) | 0% | 69.7 | 1,142,247 | Common Stock |
|
Metlife Inc
|
Khalaf Michel A. | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 206,752 | 625,273 (0%) | 0% | - | Common Stock | |
|
Metlife Inc
|
A. Khalaf Michel | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.16 per share. | 27 Feb 2024 | 113,305 | 511,968 (0%) | 0% | 69.2 | 7,836,174 | Common Stock |
|
Metlife Inc
|
A. Michel Khalaf | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 97,614 | 97,614 | - | - | Employee Stock Options (right to buy) | |
|
Metlife Inc
|
A. Michel Khalaf | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 32,534 | 418,521 (0%) | 0% | - | Common Stock | |
|
Metlife Inc
|
A. Michel Khalaf | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.15 per share. | 05 Feb 2024 | 25,181 | 406,447 (0%) | 0% | 45.1 | 1,136,922 | Common Stock |
|
Metlife Inc
|
Khalaf Michel A. | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2024 | 25,181 | 0 | - | - | Employee Stock Option (Right to Buy) | |
|
Metlife Inc
|
Khalaf A. Michel | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 65.95 per share. | 05 Feb 2024 | 20,460 | 385,987 (0%) | 0% | 65.9 | 1,349,329 | Common Stock |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 229,950 | 524,891 (0%) | 0% | - | Common Stock | |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.73 per share. | 28 Feb 2023 | 127,023 | 397,868 (0%) | 0% | 71.7 | 9,111,360 | Common Stock |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 90,967 | 90,967 | - | - | Employee Stock Options (right to buy) | |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 30,323 | 294,941 (0%) | 0% | - | Common Stock | |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.27 per share. | 28 Feb 2023 | 16,602 | 381,266 (0%) | 0% | 71.3 | 1,183,225 | Common Stock |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 72.49 per share. | 12 Dec 2022 | 57,201 | 264,618 (0%) | 0% | 72.5 | 4,146,638 | Common Stock |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.33 per share. | 12 Dec 2022 | 39,322 | 321,819 (0%) | 0% | 34.3 | 1,349,924 | Common Stock |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2022 | 39,322 | 0 | - | - | Employee Stock Option (Right to Buy) | |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2022 | 35,616 | 0 | - | - | Employee Stock Option (Right to Buy) | |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.15 per share. | 12 Dec 2022 | 35,616 | 282,497 (0%) | 0% | 31.1 | 1,109,438 | Common Stock |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.44 per share. | 01 Mar 2022 | 16,923 | 246,881 (0%) | 0% | 64.4 | 1,090,518 | Common Stock |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 199,371 | 371,881 (0%) | 0% | - | Common Stock | |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.96 per share. | 22 Feb 2022 | 108,077 | 263,804 (0%) | 0% | 69.0 | 7,452,990 | Common Stock |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 85,472 | 85,472 | - | - | Employee Stock Options (right to buy) | |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 28,495 | 172,510 (0%) | 0% | - | Common Stock | |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2021 | 52,498 | 0 | - | - | Employee Stock Options (right to buy) | |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.21 per share. | 21 Dec 2021 | 52,498 | 186,763 (0%) | 0% | 34.2 | 1,795,957 | Common Stock |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 60.74 per share. | 21 Dec 2021 | 42,748 | 144,015 (0%) | 0% | 60.7 | 2,596,535 | Common Stock |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.44 per share. | 01 Mar 2021 | 10,958 | 136,313 (0%) | 0% | 59.4 | 651,344 | Common Stock |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.96 per share. | 01 Mar 2021 | 2,048 | 134,265 (0%) | 0% | 59.0 | 120,750 | Common Stock |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 90,126 | 90,126 | - | - | Employee Stock Options (right to buy) | |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 59,662 | 176,412 (0%) | 0% | - | Common Stock | |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 30,037 | 116,750 (0%) | 0% | - | Common Stock | |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.43 per share. | 23 Feb 2021 | 29,141 | 147,271 (0%) | 0% | 57.4 | 1,673,568 | Common Stock |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2020 | 29,383 | 0 | - | - | Unit Options (Cash-Payable) | |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Sale or transfer of securities back to the company at price $ 46.31 per share. | 17 Dec 2020 | 29,383 | 31,182 (0%) | 0% | 46.3 | 1,360,727 | Common Stock |
|
Metlife Inc
|
Michel A. Khalaf | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.91 per share. | 17 Dec 2020 | 29,383 | 60,565 (0%) | 0% | 40.9 | 1,202,059 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges